ICON Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Barry Balfe
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 10.7yrs |
| Board average tenure | 8.2yrs |
Recent management updates
Recent updates
ICON: Solid Fundamentals Trump Regulatory Headwinds
Oct 22After Leaping 25% ICON Public Limited Company (NASDAQ:ICLR) Shares Are Not Flying Under The Radar
Aug 20
Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 43%?
Aug 12What Is ICON Public Limited Company's (NASDAQ:ICLR) Share Price Doing?
Jul 14We Think ICON (NASDAQ:ICLR) Can Stay On Top Of Its Debt
May 20Slammed 26% ICON Public Limited Company (NASDAQ:ICLR) Screens Well Here But There Might Be A Catch
Apr 22Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?
Mar 28ICON: An Excellent Investment Opportunity With Strong Growth Potential
Feb 24Investors Interested In ICON Public Limited Company's (NASDAQ:ICLR) Earnings
Feb 20These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well
Jan 15Is ICON Public Limited Company (NASDAQ:ICLR) Trading At A 45% Discount?
Dec 28ICON: A High Probability Of Success In The Uncertain R&D Process
Dec 13ICON: Disappointing Change In Trajectory (Rating Downgrade)
Nov 29ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)
Jul 13ICON: Will The Huge Acquisition Of PRA Continue To Create Synergies?
Feb 01CEO
Barry Balfe (46 yo)
Mr. Barry Balfe serves as Chief Executive Officer and Director at ICON Public Limited Company since October 1, 2025. He served as President of ICON Pharma Solutions at ICON Public Limited Company since 202...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Independent Non-Executive Director | no data | US$311.00k | 0.56% $ 78.2m | |
| Chief Financial Officer | 1.2yrs | US$867.00k | no data | |
| CEO & Director | less than a year | no data | no data | |
| Chief Information Officer | no data | no data | no data | |
| Chief Administrative Officer | 16.1yrs | no data | no data | |
| Director of Corporate Communications | no data | no data | no data | |
| Vice President of Marketing | no data | no data | no data | |
| Chief Human Resources Officer | 9.4yrs | no data | no data | |
| President of Corporate Investments & Partnerships | 3.1yrs | no data | no data | |
| Senior Vice President of Global Clinical Pharmacology | 16.7yrs | no data | no data | |
| Senior Vice President of Drug Development Services - CNS | 18.9yrs | no data | no data | |
| President of ICON Laboratory & Early Phase Services | 11.9yrs | no data | no data |
Experienced Management: ICLR's management team is seasoned and experienced (10.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Independent Non-Executive Director | 15.9yrs | US$311.00k | 0.56% $ 78.2m | |
| CEO & Director | less than a year | no data | no data | |
| Independent Director | 4.4yrs | US$332.00k | 0.0064% $ 898.9k | |
| Independent Non-Executive Director | 8.2yrs | US$343.00k | 0.0034% $ 468.3k | |
| Independent Non-Executive Chairman of the Board | 14.2yrs | US$658.00k | 0.026% $ 3.7m | |
| Non-Executive Director | 10.1yrs | US$4.77m | 0.058% $ 8.1m | |
| Lead Independent Director | 9.2yrs | US$387.00k | 0.0034% $ 475.3k | |
| Independent Non-Executive Director | 1.4yrs | US$50.00k | no data | |
| Independent Non-Executive Director | 6.4yrs | US$336.00k | 0.0031% $ 433.4k |
Experienced Board: ICLR's board of directors are considered experienced (8.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/24 15:19 |
| End of Day Share Price | 2025/12/23 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ICON Public Limited Company is covered by 31 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eric Coldwell | Baird |
| Douglas Tsao | Barclays |
| Luke Sergott | Barclays |